Business Description
Chunghwa Chemical Synthesis & Biotech Co Ltd
NAICS : 325412
SIC : 2834
ISIN : TW0001762003
Description
Chunghwa Chemical Synthesis & Biotech Co Ltd is engaged in research, development, manufacturing, and sales of pharmaceutical products. Geographically, it derives a majority of revenue from the United States and also has a presence in Taiwan. Its product portfolio comprises like pain management, antifungal, immunosuppressant, oncology, and Cardiovascular, Peptide Drug and Others.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.22 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.36 | |||||
| Debt-to-EBITDA | 2.22 | |||||
| Interest Coverage | 14.45 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | 2.44 | |||||
| Beneish M-Score | -2.32 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.7 | |||||
| 3-Year EBITDA Growth Rate | -11.4 | |||||
| 3-Year EPS without NRI Growth Rate | -20.7 | |||||
| 3-Year FCF Growth Rate | -111.7 | |||||
| 3-Year Book Growth Rate | 10.3 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 42.1 | |||||
| 9-Day RSI | 37.45 | |||||
| 14-Day RSI | 36.84 | |||||
| 6-1 Month Momentum % | -8.6 | |||||
| 12-1 Month Momentum % | -44.56 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.15 | |||||
| Quick Ratio | 0.69 | |||||
| Cash Ratio | 0.32 | |||||
| Days Inventory | 263.91 | |||||
| Days Sales Outstanding | 56.43 | |||||
| Days Payable | 28.85 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.87 | |||||
| Dividend Payout Ratio | 0.38 | |||||
| 3-Year Dividend Growth Rate | 17.6 | |||||
| Forward Dividend Yield % | 2.87 | |||||
| 5-Year Yield-on-Cost % | 6.47 | |||||
| Shareholder Yield % | -6.47 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.3 | |||||
| Operating Margin % | 13.46 | |||||
| Net Margin % | 12.7 | |||||
| FCF Margin % | -24.82 | |||||
| ROE % | 7.99 | |||||
| ROA % | 5.36 | |||||
| ROIC % | 5.21 | |||||
| ROC (Joel Greenblatt) % | 11.32 | |||||
| ROCE % | 8.37 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 13.32 | |||||
| PE Ratio without NRI | 13.32 | |||||
| Shiller PE Ratio | 11.94 | |||||
| PEG Ratio | 0.97 | |||||
| PS Ratio | 1.69 | |||||
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 1.05 | |||||
| EV-to-EBIT | 12.61 | |||||
| EV-to-EBITDA | 8.14 | |||||
| EV-to-Revenue | 2.13 | |||||
| EV-to-FCF | -8.37 | |||||
| Price-to-Projected-FCF | 2.43 | |||||
| Price-to-DCF (Earnings Based) | 0.43 | |||||
| Price-to-Median-PS-Value | 0.69 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.82 | |||||
| Price-to-Graham-Number | 0.79 | |||||
| Earnings Yield (Greenblatt) % | 7.94 | |||||
| FCF Yield % | -14.75 | |||||
| Forward Rate of Return (Yacktman) % | 14.88 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chunghwa Chemical Synthesis & Biotech Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 2,086.441 | ||
| EPS (TTM) (NT$) | 3.39 | ||
| Beta | 0.62 | ||
| Volatility % | 37.67 | ||
| 14-Day RSI | 36.84 | ||
| 14-Day ATR (NT$) | 0.98557 | ||
| 20-Day SMA (NT$) | 47.455 | ||
| 12-1 Month Momentum % | -44.56 | ||
| 52-Week Range (NT$) | 43.6 - 102.5 | ||
| Shares Outstanding (Mil) | 77.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chunghwa Chemical Synthesis & Biotech Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chunghwa Chemical Synthesis & Biotech Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chunghwa Chemical Synthesis & Biotech Co Ltd Frequently Asked Questions
What is Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762)'s stock price today?
The current price of TPE:1762 is NT$45.15. The 52 week high of TPE:1762 is NT$102.50 and 52 week low is NT$43.60.
When is next earnings date of Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762)?
The next earnings date of Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762) is .
Does Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762) pay dividends? If so, how much?
The Dividend Yield %  of Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762) is 2.87% (As of Today), Highest Dividend Payout Ratio of Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762) was 5.26. The lowest was 0.12. And the median was 0.33. The  Forward Dividend Yield % of Chunghwa Chemical Synthesis & Biotech Co Ltd(TPE:1762) is 2.87%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers